DCVC Bio II Overview
DCVC Bio II General Information
Description
DCVC Bio II is a venture capital fund managed by DCVC Bio. The fund is located in San Francisco, California and it targets to invest in healthcare, AI, automation, robotics sectors.
Contact Information
Fund Manager's Location
- 500 2nd Street
- Floor 2
- San Francisco, CA 94107
- United States
DCVC Bio II Investments (11)
DCVC Bio II has made a total of 11 investments. Its most recent deal was a with Avicenna Biosciences for . The deal was made on 28-Oct-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Avicenna Biosciences | 28-Oct-2025 | Biotechnology | Generating Revenue | |||
| Elo Life Systems | 12-Jan-2024 | Food Products | Generating Revenue | |||
| Totus Medicines | 15-Dec-2023 | Drug Discovery | Pre-Clinical Trials | |||
| Solu Therapeutics | 16-Sep-2023 | Drug Discovery | Clinical Trials - Phase 1 | |||
| CH4 Global | 29-Aug-2023 | Environmental Services (B2B) | Generating Revenue | |||
| Verdant Robotics | 29-Nov-2022 | Other Hardware | Generating Revenue | |||
| Syntax Bio | 03-Oct-2022 | Drug Discovery | Pre-Clinical Trials | |||
| Sabanto | 01-Jul-2022 | Machinery (B2B) | Generating Revenue | |||
| Creyon | 08-Mar-2022 | Early Stage VC (Series A) | Drug Discovery | Generating Revenue | ||
| BioPhero | 09-Mar-2021 | Later Stage VC (Series A) | Agricultural Chemicals | Generating Revenue |
DCVC Bio II Investment Strategy
DCVC Bio II Limited Partners (8)
Andra AP-fonden is one of DCVC Bio II’s 8 limited partners. Its latest Original was on 04-Aug-2020.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| Andra AP-fonden | Current | 04-Aug-2020 | Original | ||
| Dhanam Foundation | Current | 04-Aug-2020 | Original | ||
| Rhode Island State Investment Commission | Current | 04-Aug-2020 | Original | ||
| SK Networks | Current | 04-Aug-2020 | Original | ||
| Texas County & District Retirement System | Public Pension Fund | Current | 04-Aug-2020 | Original |
DCVC Bio II Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
DCVC Bio II Returns History
| Period | Contribution (by all LPs) | Dry Powder | Distribution (to all LPs) | NAV | Total Fund Distr+NAV | IRR | DPI | RVPI | TVPI | Dry Powder % |
|---|
DCVC Bio II Benchmark (95)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| Kleiner Perkins Caufield & Byers XIX | |||||
| Dragonfly Ventures II | |||||
| Tiger Global Private Investment Partners XII | |||||
| a16z crypto II | |||||
| DCVC Bio II | 30-Jun-2026 | ||||
| Celesta IV | |||||
| Lightspeed Venture Partners XIII | 30-Jun-2026 | ||||
| The Founders Fund VII | |||||
| Lightspeed Venture Partners Select IV | 30-Jun-2026 | ||||
| Pelion Ventures VII | 31-Dec-2025 |
DCVC Bio II FAQs
-
What is DCVC Bio II?
DCVC Bio II is a venture capital fund managed by DCVC Bio.
-
Who manages DCVC Bio II?
DCVC Bio II is managed by DCVC Bio.
-
Where is DCVC Bio II domiciled?
DCVC Bio II is domiciled in United States: Delaware.
-
What is DCVC Bio II's size?
DCVC Bio II has a size of $350M.
-
What type of fund is DCVC Bio II?
The fund type of DCVC Bio II is Venture.
-
What is the status of DCVC Bio II?
DCVC Bio II is closed.
-
What has DCVC Bio II invested in?
DCVC Bio II has made numerous investments in companies like Avicenna Biosciences, Elo Life Systems, and Totus Medicines within the Biotechnology, Food Products, and Drug Discovery industries.
-
What has DCVC Bio II invested in recently?
DCVC Bio II's latest investment was on 28-Oct-2025 in Avicenna Biosciences, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process